1. Home
  2. FBIZ vs PRLD Comparison

FBIZ vs PRLD Comparison

Compare FBIZ & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Business Financial Services Inc.

FBIZ

First Business Financial Services Inc.

N/A

Current Price

$69.46

Market Cap

529.7M

Sector

Finance

ML Signal

N/A

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$3.89

Market Cap

529.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBIZ
PRLD
Founded
1909
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
529.7M
529.1M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
FBIZ
PRLD
Price
$69.46
$3.89
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
★ $78.80
$9.20
AVG Volume (30 Days)
43.9K
★ 443.0K
Earning Date
10-29-2026
11-11-2026
Dividend Yield
★ 1.93%
N/A
EPS Growth
14.23
★ 23.21
EPS
★ 3.28
N/A
Revenue
N/A
★ $12,140,000.00
Revenue This Year
$9.80
$258.83
Revenue Next Year
$7.57
N/A
P/E Ratio
$21.53
★ N/A
Revenue Growth
N/A
★ 73.43
52 Week Low
$46.07
$1.16
52 Week High
$73.74
$6.83

Technical Indicators

Market Signals
Indicator
FBIZ
PRLD
Relative Strength Index (RSI) 45.24 36.85
Support Level $67.54 $3.40
Resistance Level $73.61 $4.10
Average True Range (ATR) 1.37 0.27
MACD -0.06 0.01
Stochastic Oscillator 50.63 23.90

Price Performance

Historical Comparison
FBIZ
PRLD

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: